Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest malignancies. Present-day treatments have not shown real improvements in reducing the high mortality rate and the short survival of the disease. The average survival is less than 5% after 5 years. New innovative treatments are necessary...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Mol Sci
Asıl Yazarlar: Koltai, Tomas, Reshkin, Stephan Joel, Carvalho, Tiago M. A., Cardone, Rosa A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2021
Konular:
Hypothesis
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8069142/
https://ncbi.nlm.nih.gov/pubmed/33921242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22083953
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller